Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'suicide gene' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 227 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Singh, S; Cunningham, C; Buchanan, A; Jolly, DJ; Nemunaitis, J
      Toxicity assessment of intratumoral injection of the herpes simplex type Ithymidine kinase gene delivered by retrovirus in patients with refractory cancer

      MOLECULAR THERAPY
    2. Miller, CG; Krummenacher, C; Eisenberg, RJ; Cohen, GH; Fraser, NW
      Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1

      MOLECULAR THERAPY
    3. Djeha, AH; Thomson, TA; Leung, H; Searle, PF; Young, LS; Kerr, DJ; Harris, PA; Mountain, A; Wrighton, CJ
      Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors

      MOLECULAR THERAPY
    4. Fukui, T; Hayashi, Y; Kagami, H; Yamamoto, N; Fukuhara, H; Tohnai, I; Ueda, M; Mizuno, M; Yoshida, J
      Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector

      ORAL ONCOLOGY
    5. Otomo, T; Yamamoto, S; Morishita, R; Kaneda, Y
      EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy

      JOURNAL OF GENE MEDICINE
    6. Liu, C; Kong, B; Xia, HH; Ellem, KAO; Wei, MQ
      VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death

      JOURNAL OF GENE MEDICINE
    7. Xu, G; McLeod, HL
      Strategies for enzyme/prodrug cancer therapy

      CLINICAL CANCER RESEARCH
    8. Sato, N; Kobayashi, H; Saga, T; Nakamoto, Y; Ishimori, T; Togashi, K; Fujibayashi, Y; Konishi, J; Brechbiel, MW
      Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice

      CLINICAL CANCER RESEARCH
    9. Aframian, DJ; Zheng, C; Goldsmith, CM; Nikolovski, J; Cukierman, E; Yamada, KM; Mooney, DJ; Birkedal-Hansen, H; Baum, BJ
      Using HSV-thymidine kinase for safety in an allogeneic salivary graft cellline

      TISSUE ENGINEERING
    10. Chmura, SJ; Gupta, N; Advani, SJ; Kufe, DW; Weichselbaum, RR
      Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation

      SEMINARS IN RADIATION ONCOLOGY
    11. Paquin, A; Jaalouk, DE; Galipeau, J
      Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for celland gene therapy applications

      HUMAN GENE THERAPY
    12. Kawamura, K; Bahar, R; Namba, H; Seimiya, M; Takenaga, K; Hamada, H; Sakiyama, S; Tagawa, M
      Bystander effect in uracil phosphoribosyltransferase 5-fluorouracil-mediated suicide gene therapy is correlated with the level of intercellular communication

      INTERNATIONAL JOURNAL OF ONCOLOGY
    13. Tang, ZY
      Hepatocellular carcinoma-cause, treatment and metastasis

      WORLD JOURNAL OF GASTROENTEROLOGY
    14. Eaton, JD; Perry, MJA; Todryk, SM; Mazucco, RA; Kirby, RS; Griffiths, JR; Dalgleish, AG
      Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques

      GENE THERAPY
    15. Sandalon, Z; Fusenig, NE; McCutcheon, J; Taichman, LB; Garlick, JA
      Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia

      GENE THERAPY
    16. Wybranietz, WA; Gross, CD; Phelan, A; O'Hare, P; Spiegel, M; Graepler, F; Bitzer, M; Stahler, P; Gregor, M; Lauer, UM
      Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosinedeaminase (CD) fusion gene

      GENE THERAPY
    17. Humphreys, MJ; Ghaneh, P; Greenhalf, W; Campbell, F; Clayton, TM; Everett, P; Huber, BE; Richards, CA; Ford, MJ; Neoptolemos, JP
      Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases

      GENE THERAPY
    18. Hawkins, LK; Johnson, L; Bauzon, M; Nye, JA; Castro, D; Kitzes, GA; Young, MD; Holt, JK; Trown, P; Hermiston, TW
      Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

      GENE THERAPY
    19. Hawkins, LK; Hermiston, TW
      Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

      GENE THERAPY
    20. Heine, D; Muller, R; Brusselbach, S
      Cell surface display of a lysosomal enzyme for extracellular gene-directedenzyme prodrug therapy

      GENE THERAPY
    21. Lambright, ES; Amin, K; Wiewrodt, R; Force, SD; Lanuti, M; Propert, KJ; Litzky, L; Kaiser, LR; Albelda, SM
      Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

      GENE THERAPY
    22. Kobayashi, N; Noguchi, H; Totsugawa, T; Watanabe, T; Matsumura, T; Fujiwara, T; Miyazaki, M; Fukaya, K; Namba, M; Tanaka, N
      Insertion of a suicide gene into an immortalized human hepatocyte cell line

      CELL TRANSPLANTATION
    23. Dilber, MS; Gahrton, G
      Suicide gene therapy: possible applications in haematopoietic disorders

      JOURNAL OF INTERNAL MEDICINE
    24. Tiberghien, P
      Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantation

      JOURNAL OF INTERNAL MEDICINE
    25. Yoon, SK; Armentano, D; Wands, JR; Mohr, L
      Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice

      CANCER GENE THERAPY
    26. Shimizu, T; Shimada, H; Ochiai, T; Hamada, H
      Enhanced growth suppression in esophageal carcinoma cells using adenovirus-mediated fusion gene transfer (uracil phosphoribosyl transferase and herpes simplex virus thymidine kinase)

      CANCER GENE THERAPY
    27. Namba, H; Iwadate, Y; Kawamura, K; Sakiyama, S; Tagawa, M
      Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells

      CANCER GENE THERAPY
    28. Hamel, W; Zirkel, D; Mehdorn, HM; Westphal, M; Israel, MA
      (E)-5-(2-bromovinyl)-2 '-deosyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase-expressing cells

      CANCER GENE THERAPY
    29. McNeish, IA; Tenev, T; Bell, S; Marani, M; Vassaux, G; Lemoine, N
      Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells

      CANCER GENE THERAPY
    30. Karle, P; Renner, M; Salmons, B; Gunzburg, WH
      Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide

      CANCER GENE THERAPY
    31. Kanazawa, T; Urabe, M; Mizukami, H; Okada, T; Kume, A; Nishino, H; Monahan, J; Kitamura, K; Ichimura, K; Ozawa, K
      gamma-Rays enhance rAAV-mediated transgene expression and cytocidal effectof AAV-HSVtk/ganciclovir on cancer cells

      CANCER GENE THERAPY
    32. Agard, C; Ligeza, C; Dupas, B; Izembart, A; El Kouri, C; Moullier, P; Ferry, N
      Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis

      CANCER GENE THERAPY
    33. Sakai, Y; Kaneko, S; Nakamoto, Y; Kagaya, T; Mukaida, N; Kobayashi, K
      Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma

      CANCER GENE THERAPY
    34. Valerie, K; Hawkins, W; Farnsworth, J; Schmidt-Ullrich, R; Lin, PS; Amir, C; Feden, J
      Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir

      CANCER GENE THERAPY
    35. Nagayama, Y; Nishihara, E; Namba, H; Yokoi, H; Hasegawa, M; Mizuguchi, H; Hayakawa, T; Hamada, H; Yamashita, S; Niwa, M
      Targeting the replication of adenovirus to p53-defective thyroid carcinomawith a p53-regulated Cre/loxP system

      CANCER GENE THERAPY
    36. Okino, T; Onda, M; Matsukura, N; Inada, K; Tatematsu, M; Suzuki, S; Shimada, T
      Sequential histopathological changes in vivo after suicide gene therapy ofgastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats

      JAPANESE JOURNAL OF CANCER RESEARCH
    37. Chaum, E
      Comparative analysis of the uptake and expression of plasmid vectors in human ciliary and retinal pigment epithelial cells in vitro

      JOURNAL OF CELLULAR BIOCHEMISTRY
    38. Jordan, JF; Kociok, N; Grisanti, S; Jacobi, PC; Esser, JM; Luther, TT; Krieglstein, GK; Esser, P
      Specific features of apoptosis in human lens epithelial cells induced by mitomycin C in vitro

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    39. Gerolami, R; Uch, R; Cardoso, J; Bagnis, C; Mannoni, P; Brechot, C
      Gene therapy for hepatocellular carcinoma. From the idea to clinical trials

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    40. Tanaka, M; Inase, N; Miyake, S; Yoshizawa, Y
      Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma

      ANTICANCER RESEARCH
    41. Morimoto, E; Inase, N; Mlyake, S; Yoshizawa, Y
      Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter

      ANTICANCER RESEARCH
    42. Wang, LH; Ju, DW; Sun, YH; Tao, Q; Qian, SX; Mi, J; Hamada, H; Cao, XT
      The potent antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    43. Sakamoto, T; Ikeda, Y; Yonemitsu, Y
      Gene targeting to the retina

      ADVANCED DRUG DELIVERY REVIEWS
    44. Wutzler, P; Thust, R
      Genetic risks of antiviral nucleoside analogues - a survey

      ANTIVIRAL RESEARCH
    45. Sakai, Y; Kaneko, S; Sato, Y; Kanegae, Y; Tamaoki, T; Saito, I; Kobayashi, K
      Gene therapy for hepatocellular carcinoma using two recombinant adenovirusvectors with alpha-fetoprotein promoter and Cre/lox P system

      JOURNAL OF VIROLOGICAL METHODS
    46. Suzuki, K; Curiel, DT
      Viral cancer therapy

      REVISTA DE INVESTIGACION CLINICA
    47. Zheng, XY; Johansson, M; Karlsson, A
      Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea

      MOLECULAR PHARMACOLOGY
    48. Doronin, K; Kuppuswamy, M; Toth, K; Tollefson, AE; Krajcsi, P; Krougliak, V; Wold, WSM
      Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

      JOURNAL OF VIROLOGY
    49. Mikola, MK; Rahman, NA; Paukku, TH; Ahtiainen, PM; Vaskivuo, TE; Tapanainen, JS; Poutanen, M; Huhtaniemi, IT
      Gonadal tumors of mice double transgenic for inhibin-alpha promoter-drivensimian virus 40 T-antigen and herpes simplex virus thymidine kinase are sensitive to ganciclovir treatment

      JOURNAL OF ENDOCRINOLOGY
    50. Greco, O; Dachs, GU
      Gene directed Enzyme/Prodrug therapy of cancer: Historical appraisal and future prospectives

      JOURNAL OF CELLULAR PHYSIOLOGY
    51. Chen, BM; Cheng, TL; Tzou, SC; Roffler, SR
      Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy

      INTERNATIONAL JOURNAL OF CANCER
    52. Black, ME; Kokoris, MS; Sabo, P
      Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve produrg-mediated tumor cell killing

      CANCER RESEARCH
    53. Matsubara, S; Wada, Y; Gardner, TA; Egawa, M; Park, MS; Hsieh, CL; Zhau, HE; Kao, C; Kamidono, S; Gillenwater, JY; Chung, LWK
      A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis

      CANCER RESEARCH
    54. Chowers, I; Banin, E; Hemo, Y; Porat, R; Falk, H; Keshet, E; Pe'er, J; Panet, A
      Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity

      BRITISH JOURNAL OF OPHTHALMOLOGY
    55. Liu, JL; Anderson, BE; Robert, ME; McNiff, JM; Emerson, SG; Shlomchik, WD; Shlomchik, MJ
      Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease

      BLOOD
    56. Liao, KW; Chou, WC; Lo, YC; Roffler, SR
      Design of transgenes for efficient expression of active chimeric proteins on mammalian cells

      BIOTECHNOLOGY AND BIOENGINEERING
    57. Zheng, XY; Johansson, M; Karlsson, A
      Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    58. Sanda, A; Zhu, CY; Johansson, M; Karlsson, A
      Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    59. Zisman, A; Pantuck, AJ; Belldegrun, A
      Gene and immune-based therapies for genitourinary malignancies: Current status and future prospects

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    60. Braunberger, E; Cohen, JL; Boyer, O; Pegaz-Fiornet, B; Raynal-Raschilas, N; Bruneval, P; Thomas-Vaslin, V; Bellier, B; Carpentier, A; Glotz, D; Klatzmann, D
      T-cell suicide gene therapy for organ transplantation: Induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression

      MOLECULAR THERAPY
    61. Drake, RR; Pitlyk, K; McMasters, RA; Mercer, KE; Young, H; Moyer, MP
      Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line

      MOLECULAR THERAPY
    62. Alvarez, RD; Gomez-Navarro, J; Wang, MH; Barnes, MN; Strong, TV; Arani, RB; Arafat, W; Hughes, JV; Siegal, GP; Curiel, DT
      Adenoviral-mediated suicide gene therapy for ovarian cancer

      MOLECULAR THERAPY
    63. Trask, TW; Trask, RP; Aguilar-Cordova, E; Shine, HD; Wyde, PR; Goodman, JC; Hamilton, WJ; Rojas-Martinez, A; Chen, SH; Woo, SLC; Grossman, RG
      Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors

      MOLECULAR THERAPY
    64. Morris, JC; Wildner, O
      Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

      MOLECULAR THERAPY
    65. Vassaux, G; Lemoine, NR
      Gene therapy for carcinoma of the breast - Genetic toxins

      BREAST CANCER RESEARCH
    66. Cheon, J; Kim, HK; Moon, DG; Yoon, DK; Cho, JH; Koh, SK
      Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity

      BJU INTERNATIONAL
    67. Weissinger, EM; Franz, M; Voss, C; Bonini, C; Kremmer, E; Kolb, HJ
      Expression of HSV-TK suicide gene in primary T lymphocytes: The dog as a preclinical model

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    68. Bateman, AR; Harrington, KJ; Melcher, AA; Vile, RG
      Cancer gene therapy: developments to 2000

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    69. Cavazzana-Calvo, M; Le Deist, F; Hacein-Bey, S; Fischer, A
      Is it possible to speed up T cell function development following T cell depleted HLA incompatible stem cell tansplantation?

      EUROPEAN CYTOKINE NETWORK
    70. Pierrefite-Carle, V; Baque, P; Gavelli, A; Benchimol, D; Bourgeon, A; Milano, G; Saint-Paul, MC; Rossi, B
      Regression of experimental liver tumor after distant intra-hepatic injection of cytosine deaminase-expressing tumor cells and 5-fluorocytosine treatment

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    71. Aghi, M; Hochberg, F; Breakefield, XO
      Prodrug activation enzymes in cancer gene therapy

      JOURNAL OF GENE MEDICINE
    72. Curiel, DT
      The development of conditionally replicative adenoviruses for cancer therapy

      CLINICAL CANCER RESEARCH
    73. Link, CJ; Seregina, T; Traynor, A; Burt, RK
      Cellular suicide therapy of malignant disease

      STEM CELLS
    74. Zhang, RS; DeGroot, LJ
      Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: Relationship of bystander effect and antitumor efficacy

      THYROID
    75. Introna, M; Barbui, AM; Bambacioni, F; Casati, C; Gaipa, G; Borleri, G; Bernasconi, S; Barbui, T; Golay, J; Biondi, A; Rambaldi, A
      Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies

      HUMAN GENE THERAPY
    76. Qiao, J; Black, ME; Caruso, M
      Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

      HUMAN GENE THERAPY
    77. Boyer, O; Cohen, JL; Bellier, B; Thomas-Vaslin, V; Klatzmann, D; Saron, MF
      Transient control of a virus-induced immunopathology by generic immunosuppression

      GENE THERAPY
    78. Vile, RG; Russell, SJ; Lemoine, NR
      Cancer gene therapy: hard lessons and new courses

      GENE THERAPY
    79. Mohr, L; Rainov, NG; Mohr, UG; Wands, JR
      Rabbit cytochrome P4504B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma

      CANCER GENE THERAPY
    80. Valerie, K; Brust, D; Farnsworth, J; Amir, C; Taher, MM; Hershey, C; Feden, J
      Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir

      CANCER GENE THERAPY
    81. Rivas, C; Chandler, P; Melo, JV; Simpson, E; Apperley, JF
      Absence of in vitro or in vivo bystander effects in a thymidine kinase-transduced murine T lymphoma

      CANCER GENE THERAPY
    82. McMasters, RA; Wilbert, TN; Jones, KE; Pitlyk, K; Saylors, RL; Moyer, MP; Chambers, TC; Drake, RR
      Two-drug combinations that increase apoptosis and modulate Bak and Bcl-X-Lexpression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase

      CANCER GENE THERAPY
    83. Candotti, F; Agbaria, R; Mullen, CA; Touraine, R; Balzarini, J; Johns, DG; Blaese, RM
      Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric genefor metabolic suicide gene transfer

      CANCER GENE THERAPY
    84. Kawamura, K; Tasaki, K; Hamada, H; Takenaga, K; Sakiyama, S; Tagawa, M
      Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity

      CANCER GENE THERAPY
    85. Cao, XT; Huang, X; Ju, DW; Zhang, WP; Hamada, H; Wang, JL
      Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase genetherapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer

      CANCER GENE THERAPY
    86. Grignet-Debrus, C; Cool, V; Baudson, N; Velu, T; Calberg-Bacq, CM
      The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella tester and Herpes simplex viral thymidine kinases in suicide gene therapy

      CANCER GENE THERAPY
    87. Spooner, RA; Martin, J; Friedlos, F; Marais, R; Springer, CJ
      In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug

      CANCER GENE THERAPY
    88. Harada, Y; Iwai, M; Tanaka, S; Okanoue, T; Kashima, K; Maruyama-Tabata, H; Hirai, H; Satoh, E; Imanishi, J; Mazda, O
      Highly efficient suicide gene expression in hepatocellular carcinoma cellsby Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer

      CANCER GENE THERAPY
    89. Ichikawa, T; Tamiya, T; Adachi, Y; Ono, Y; Matsumoto, K; Furuta, T; Yoshida, Y; Hamada, H; Ohmoto, T
      In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

      CANCER GENE THERAPY
    90. Westphal, EM; Ge, JQ; Catchpole, JR; Ford, M; Kenney, SC
      The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: Induction of bystander killing in vitro and in vivo

      CANCER GENE THERAPY
    91. Kruse, CA; Lamb, C; Hogan, S; Smiley, WR; Kleinschmidt-DeMasters, BK; Burrows, FJ
      Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms

      CANCER GENE THERAPY
    92. Vogt, J; Perozzo, R; Pautsch, A; Prota, A; Schelling, P; Pilger, P; Folkers, G; Scapozza, L; Schulz, GE
      Nucleoside binding site of Herpes simplex type 1 thymidine kinase analyzedby X-ray crystallography

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    93. Chaum, E; Hatton, MP; Stein, G
      Polyplex-mediated gene transfer into human retinal pigment epithelial cells in vitro

      JOURNAL OF CELLULAR BIOCHEMISTRY
    94. Kawamura, K; Namba, H; Bahar, R; Miyauchi, M; Maeda, T; Hamada, H; Sakiyama, S; Tagawa, M
      Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts

      CANCER LETTERS
    95. Kokoris, MS; Sabo, P; Black, ME
      In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy

      ANTICANCER RESEARCH
    96. Chen, XK; Zhang, DX; Dennert, G; Hung, G; Lee, AS
      Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter

      BREAST CANCER RESEARCH AND TREATMENT
    97. Bzowska, A; Kulikowska, E; Shugar, D
      Purine nucleoside phosphorylases: properties, functions, and clinical aspects

      PHARMACOLOGY & THERAPEUTICS
    98. Kuriyama, S; Matsumoto, M; Mitoro, A; Tsujinoue, H; Nakatani, T; Fukui, H; Tsujii, T
      Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model

      DIGESTIVE DISEASES AND SCIENCES
    99. Chang, JW; Lee, H; Kim, E; Lee, Y; Chung, SS; Kim, JH
      Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma

      NEUROSURGERY
    100. Hauswirth, WW; Beaufrere, L
      Ocular gene therapy: Quo vadis?

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 01:40:29